Welcome to Chemzonepharma Inc
Exporter / Supplier Of Methotrexate, Avastin Injections, Herceptin, Alimta, Avonex, Stelara, Orencia, Invega Sustenna, Avonex Pen
Welcome to Chemzonepharma Inc
Exporter / Supplier Of Methotrexate, Avastin Injections, Herceptin, Alimta, Avonex, Stelara, Orencia, Invega Sustenna, Avonex Pen

Methotrexate, formerly known as amethopterin, is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions

AVONEX is a 166 amino acid glycoprotein with a molecular weight of approximately 22, 500 daltons. It is produced by recombinant DNA technology using genetically engineered Chinese Hamster Ovary cells into which the human interferon beta gene has been introduced. The amino acid sequence of AVONEX is identical to that of natural human interferon beta. Using the World Health Organization (WHO) International Standard for Interferon, AVONEX has a specific activity of approximately 200 million international units of antiviral activity per mg of interferon beta-1a determined specifically by an in vitro cytopathic effect bioassay using lung carcinoma cells (A549) and Encephalomyocarditis virus (ECM). AVONEX 30 micrograms contains approximately 6 million international units of antiviral activity using this method. The activity against other standards is not known. Comparison of the activity of AVONEX with other interferon betas is not appropriate, because of differenc

Bevacizumab, sold under the trade name Avastin, is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels. Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A).[2] VEGF-A is a chemical signal that stimulates angiogenesis in a variety of diseases, especially in cancer. Bevacizumab was the first clinically available angiogenesis inhibitor in the United States.[3] Bevacizumab was approved by the U.S. Food and Drug Administration (FDA) for certain metastatic cancers. It received its first approval in 2004, for combination use with standard chemotherapy for metastatic colon cancer.[4] It has since been approved for use in certain lung cancers, renal cancers, ovarian cancers, and glioblastoma multiforme of the brain. It had been approved for breast cancer, but that approval was withdrawn when later studies showed no evidence of effectiveness.[5] It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system.[6] It is listed for its use in treating certain eye diseases.[6]






Share your thoughts with other customers for Chemzonepharma Inc
Add Review